Back to Press

NICE approves Palforzia for NHS use

21st January 2022

Independent organisation NICE recommends Palforzia for NHS use in draft guidance which says the drug can be effective in inducing tolerance to peanuts and reducing the severity of allergic reactions, including potentially life-threatening anaphylaxis. Read more in Pharmaphorum here.

Life-changing’ study helps severely allergic children to build up tolerance, The Independent

Girl, severely allergic to peanuts, can now eat SEVEN safely, The Sun

Peanut allergy girl life “changed” after trial treatment, Radio 4

Find out if your child is suitable,
just complete our simple questionnaire

Check if your child is suitable

NOTICE

Details of the cost of treatment are outlined in a separate section of the website however the overall cost of the programme can be high.

Payment for the first year of treatment is required up front at the start of treatment, although payment plans are available if required. If you are not able to complete the course of treatment for any reason, there is a detailed refund policy.

Please acknowledge you have read this before continuing.

Acknowledge Cancel

Testimonials

Here’s what our patients have to say…

Each member of the team that we dealt with, whether medical or support staff, were excellent.

The support has been excellent throughout.

We had a clear plan from early in the process and managed to follow through with only a couple of amendments (which we made).

We have been impressed and very grateful for the speed at which our queries have been responded to.

Parents of Isaac, age 9, Isle of Wight

Excellent. All of the team were very efficient and we found the chart with the dates and dosage for the updosing appointments particularly helpful.

The team were easy to reach, including direct contact with the consultants, even at the weekend and over holiday periods.

The overall experience was excellent.

Parents of Ernie, age 7, Nottingham

More